Published in Am J Pathol on October 01, 1986
Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A (1991) 4.56
Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest (1991) 3.82
Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol (1989) 3.82
Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest (1988) 3.76
Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J (1993) 3.54
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A (1989) 3.37
Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest (1996) 3.10
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest (1996) 2.96
Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1998) 2.93
Cell proliferation in human coronary arteries. Proc Natl Acad Sci U S A (1990) 2.90
Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest (1993) 2.60
Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest (1991) 2.58
Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. Am J Pathol (1995) 2.54
Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol (2001) 2.38
Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest (1991) 2.35
Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci U S A (1988) 2.32
Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest (1990) 2.29
Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci U S A (2003) 2.17
Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol (1992) 2.12
Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A (1995) 2.00
Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol (1990) 1.88
Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol (1989) 1.87
Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J Clin Invest (1992) 1.83
Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J Clin Invest (1991) 1.79
Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. J Clin Invest (1988) 1.76
In stent restenosis: bane of the stent era. J Clin Pathol (2006) 1.71
Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol (1992) 1.66
Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci U S A (1994) 1.63
Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells. J Exp Med (1987) 1.61
Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis. Am J Pathol (1991) 1.59
HHF35, a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues. Am J Pathol (1987) 1.58
Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A (1991) 1.55
Expression of extra domain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent. J Cell Biol (1989) 1.54
Role of human immunodeficiency virus and cytomegalovirus in AIDS encephalitis. Am J Pathol (1988) 1.49
Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am J Pathol (1993) 1.46
Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification. Am J Pathol (1993) 1.45
Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. Am J Pathol (1994) 1.42
Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J Clin Invest (1990) 1.42
Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest (1993) 1.41
Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J Clin Invest (1992) 1.40
Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am J Pathol (1990) 1.40
Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc Natl Acad Sci U S A (1988) 1.38
Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol (1996) 1.38
Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J Clin Invest (1993) 1.36
Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am J Pathol (1993) 1.30
Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis. Am J Pathol (1990) 1.28
Oxidative risk for atherothrombotic cardiovascular disease. Free Radic Biol Med (2009) 1.24
Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest (1994) 1.23
Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine. J Clin Invest (1992) 1.22
Human atherosclerosis. IV. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults. Am J Pathol (1993) 1.20
Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J Clin Invest (1993) 1.19
Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults. Am J Pathol (1992) 1.18
Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest (1995) 1.17
High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci U S A (1991) 1.17
Human immunodeficiency virus (HIV) and JC virus in acquired immune deficiency syndrome (AIDS) patients with progressive multifocal leukoencephalopathy. Acta Neuropathol (1988) 1.16
Immune interferon inhibits proliferation and induces 2'-5'-oligoadenylate synthetase gene expression in human vascular smooth muscle cells. J Clin Invest (1989) 1.15
Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry. Am J Pathol (1993) 1.15
Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J (1988) 1.14
Myeloid cells in atherosclerosis: initiators and decision shapers. Semin Immunopathol (2009) 1.13
Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta. Am J Pathol (1998) 1.13
Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol (1994) 1.13
Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A. Am J Pathol (1993) 1.12
Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B. Am J Pathol (1991) 1.11
Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. Am J Pathol (1992) 1.10
Immune and inflammatory mechanisms in the development of atherosclerosis. Br Heart J (1993) 1.09
Dual 12/15- and 5-lipoxygenase deficiency in macrophages alters arachidonic acid metabolism and attenuates peritonitis and atherosclerosis in ApoE knock-out mice. J Biol Chem (2009) 1.08
Intimal proliferation in an organ culture of human saphenous vein. Am J Pathol (1990) 1.07
Active collagen synthesis by pulmonary arteries in human primary pulmonary hypertension. Am J Pathol (1993) 1.04
Macrophage differentiation in atherosclerosis. An in situ immunohistochemical analysis in humans. Am J Pathol (1992) 1.04
The significance of vascular inflammation in rheumatoid arthritis. Ann Rheum Dis (1994) 1.02
Monocyte-to-macrophage differentiation: synthesis and secretion of a complex extracellular matrix. J Biol Chem (2012) 1.02
Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice. Am J Pathol (1996) 1.01
Macrophages promote polycystic kidney disease progression. Kidney Int (2013) 1.01
Platelet-derived growth factor activity and mRNA expression in healing vascular grafts in baboons. Association in vivo of platelet-derived growth factor mRNA and protein with cellular proliferation. J Clin Invest (1991) 1.00
Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. J Clin Invest (1994) 1.00
Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion. J Clin Invest (1995) 1.00
Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. Am J Pathol (1994) 1.00
Galectin-3 expression in human atherosclerotic lesions. Am J Pathol (1998) 0.99
Tissue-resident macrophages are productively infected ex vivo by primary X4 isolates of human immunodeficiency virus type 1. J Virol (2005) 0.99
Association of low numbers of CD206-positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesis. Neurogastroenterol Motil (2014) 0.99
Lipoprotein(a) and its role in occlusive vascular disease. Ann R Coll Surg Engl (1993) 0.99
Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries. J Clin Invest (1993) 0.99
Increased interleukin-1 beta and fibronectin expression are early features of the development of the postcardiac transplant coronary arteriopathy in piglets. Am J Pathol (1993) 0.98
Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions. J Clin Invest (1989) 0.96
Evidence for multiple pathologic and protective mechanisms of murine cerebral malaria. Infect Immun (1998) 0.96
Interleukin 1 regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells. Proc Natl Acad Sci U S A (1991) 0.94
Gap junctional communication between vascular cells. Induction of connexin43 messenger RNA in macrophage foam cells of atherosclerotic lesions. Am J Pathol (1993) 0.92
Regional expression of the platelet-derived growth factor and its receptors in a primate graft model of vessel wall assembly. J Clin Invest (1993) 0.90
Lipoproteins modulate expression of the macrophage scavenger receptor. Am J Pathol (1998) 0.90
Upregulation of fibronectin synthesis by interleukin-1 beta in coronary artery smooth muscle cells is associated with the development of the post-cardiac transplant arteriopathy in piglets. J Clin Invest (1993) 0.90
Heterogeneity of smooth muscle cells in atheromatous plaque of human aorta. Am J Pathol (1990) 0.89
Active macrophage-associated TGF-beta co-localizes with type I procollagen gene expression in atherosclerotic human pulmonary arteries. Am J Pathol (1995) 0.89
Matrix metalloproteinase-9 (92-kd gelatinase/type IV collagenase equals gelatinase B) can degrade arterial elastin. Am J Pathol (1994) 0.88
Macrophage histology in paraffin-embedded multiple sclerosis plaques is demonstrated by the monoclonal pan-macrophage marker HAM-56: correlation with chronicity of the lesion. Acta Neuropathol (1990) 0.87
Immunology of atherosclerosis: the promise of mouse models. Am J Pathol (1996) 0.85
Simultaneous detection of ferritin and HIV-1 in reactive microglia. Acta Neuropathol (1992) 0.85
Expression of collagen, interstitial collagenase, and tissue inhibitor of metalloproteinases-1 in restenosis after carotid endarterectomy. Am J Pathol (1996) 0.84
Phenotypic change and accumulation of smooth muscle cells in strictures in Crohn's disease: relevance to local angiotensin II system. J Gastroenterol (2010) 0.84
Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (1975) 83.56
"Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem (1981) 71.15
The pathogenesis of atherosclerosis--an update. N Engl J Med (1986) 14.59
The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol (1971) 10.72
The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol (1981) 5.86
Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis (1986) 5.23
Intimal vascularization and atherosclerosis. J Pathol Bacteriol (1951) 5.03
The smooth muscle cell in culture. Physiol Rev (1979) 5.03
Antihemophilic factor antigen. Localization in endothelial cells by immunofluorescent microscopy. J Clin Invest (1973) 4.57
Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis (1984) 4.40
Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry. J Histochem Cytochem (1982) 3.88
Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. N Engl J Med (1983) 3.63
Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med (1984) 3.41
Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. Am J Pathol (1980) 3.35
Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest (1982) 3.29
Monoclonal antibody to a human leukocyte-specific membrane glycoprotein probably homologous to the leukocyte-common (L-C) antigen of the rat. Eur J Immunol (1980) 3.10
Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. IV. Investigation of macrophage-like properties of aortic cell populations. Lab Invest (1979) 2.79
Fine structure of human aortic intimal thickening and fatty streaks. Lab Invest (1965) 2.53
Monoclonal antibodies to intermediate filament proteins of human cells: unique and cross-reacting antibodies. J Cell Biol (1982) 2.45
Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues. Am J Pathol (1984) 2.42
Immunohistological analysis of human mononuclear phagocytes and dendritic cells by using monoclonal antibodies. Lab Invest (1986) 2.42
A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. J Cell Biol (1985) 2.38
Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol (1984) 2.29
Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am J Pathol (1986) 2.26
Cytoskeleton of rat aortic smooth muscle cells. Normal conditions and experimental intimal thickening. Lab Invest (1984) 2.15
Human dendritic cells and macrophages. In situ immunophenotypic definition of subsets that exhibit specific morphologic and microenvironmental characteristics. Am J Pathol (1985) 2.10
Stable variants affecting B cell alloantigens in human lymphoid cells. Nature (1978) 2.07
Endothelial cells and the biology of factor VIII. N Engl J Med (1977) 2.03
Monocytic origin of foam cells in human atherosclerotic plaques. Atherosclerosis (1984) 1.78
Comparison of abdominal and thoracic aortic medial structure in mammals. Deviation of man from the usual pattern. Circ Res (1969) 1.74
Identification of foam cells in human atherosclerotic lesions as macrophages using monoclonal antibodies. Arch Pathol Lab Med (1985) 1.36
Vimentin-containing smooth muscle cells in aortic intimal thickening after endothelial injury. Lab Invest (1982) 1.34
Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies. J Pathol (1985) 1.34
Role of macrophages in atherosclerosis. Sequential observations of cholesterol-induced rabbit aortic lesion by the immunoperoxidase technique using monoclonal antimacrophage antibody. Lab Invest (1985) 1.31
The distribution of collagen types I, III and V (AB) in normal and atherosclerotic human aorta. J Pathol (1980) 1.15
Characterization of cell populations isolated from aortas of rhesus monkeys with experimental atherosclerosis. Circ Res (1980) 1.04
CGA-7 and HHF, two monoclonal antibodies that recognize muscle actin and react with adherent cells in human long-term bone marrow cultures. Blood (1985) 0.96
Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cells. Am J Pathol (1984) 0.94
Actomyosin and myosin and the deposition of lipids and serum lipoproteins. Arch Pathol (1967) 0.89
Immunohistochemical localization of apolipoprotein B in human atherosclerotic lesions. Arch Pathol Lab Med (1984) 0.88
Plaque localization and distribution of vasa vasorum. A micro-angiological study of the human abdominal aorta. Angiologica (1966) 0.88
Histochemical detection and quantification of macrophages in rhesus and cynomolgus monkey atherosclerotic lesions. J Histochem Cytochem (1984) 0.85
Apolipoprotein B (Apo B) in vein graft atherosclerosis. An immunoperoxidase study. Atherosclerosis (1980) 0.83
[Immunomorphologic characteristics of the distribution of collagen types I, III, IV and V in normal intima and in atherosclerosis of the major arteries and aorta in man]. Arkh Patol (1984) 0.83
The role of macrophages in atherosclerosis. Haematol Blood Transfus (1981) 0.83
Changes in the vasa vasorum of the atherosclerotic aortic wall. Angiologica (1968) 0.83
Immune deposits in human aortic atherosclerotic wall. Med Interne (1983) 0.83
A technique for localizing LDL by immunofluorescence in formalin-fixed and paraffin-embedded atherosclerotic lesions. Artery (1980) 0.82
Non-specific esterase activity during regression of swine aortic atherosclerosis. Artery (1980) 0.81
The pathogenesis of atherosclerosis--an update. N Engl J Med (1986) 14.59
The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol (1971) 10.72
A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A (1974) 9.94
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb (1994) 8.54
The biology of platelet-derived growth factor. Cell (1986) 7.17
Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A (1987) 6.76
The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol (1975) 6.42
Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science (1973) 6.38
The pathogenesis of atherosclerosis (second of two parts). N Engl J Med (1976) 5.48
Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985) (2000) 5.24
The pathogenesis of atherosclerosis (first of two parts). N Engl J Med (1976) 5.22
The smooth muscle cell in culture. Physiol Rev (1979) 5.03
Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (1985) (1998) 5.01
A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell (1985) 4.81
The platelet-derived growth factor. Cell (1978) 4.77
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet (1997) 4.72
The elastic fiber. I. The separation and partial characterization of its macromolecular components. J Cell Biol (1969) 4.51
Clear cell tumor of the lung. Immunohistochemical and ultrastructural evidence of melanogenesis. Am J Surg Pathol (1991) 4.48
Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis (1984) 4.40
Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation (1994) 4.32
Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science (1991) 4.27
A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol (1976) 3.86
A novel ES cell line, TT2, with high germline-differentiating potency. Anal Biochem (1993) 3.79
The fibroblast and wound repair. Biol Rev Camb Philos Soc (1968) 3.78
The fine structure of elastic fibers. J Cell Biol (1966) 3.68
Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol (1998) 3.66
Two classes of PDGF receptor recognize different isoforms of PDGF. Science (1988) 3.59
Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol (1985) (2000) 3.54
Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate. J Cell Biol (1976) 3.48
Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol (1989) 3.43
Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood. Am J Pathol (1995) 3.37
Platelet-derived growth factor. I. High yield purification and evidence for multiple forms. J Biol Chem (1982) 3.35
Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem (1989) 3.33
Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol (1985) (2000) 3.31
Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science (1990) 3.27
Platelet-derived growth factor. II. Specific binding to cultured cells. J Biol Chem (1982) 3.20
Wound healing and collagen formation. V. Quantitative electron microscope radioautographic observations of proline-H3 utilization by fibroblasts. J Cell Biol (1965) 3.18
Experimental arteriosclerosis. I. Fibrous plaque formation in primates, an electron microscope study. J Exp Med (1972) 3.17
Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. J Clin Oncol (1999) 3.04
Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest (1976) 3.04
PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol (1990) 3.04
Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science (1989) 2.98
Similar effects of platelet-derived growth factor and epidermal growth factor on the phosphorylation of tyrosine in cellular proteins. Cell (1982) 2.92
HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. Am J Pathol (1987) 2.91
Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res (1988) 2.90
TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell (1990) 2.82
Coordinate control of 3T3 cell proliferation by platelet-derived growth factor and plasma components. Proc Natl Acad Sci U S A (1978) 2.80
Early changes in phosphatidylinositol and arachidonic acid metabolism in quiescent swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J Biol Chem (1981) 2.77
The smooth muscle cell. I. In vivo synthesis of connective tissue proteins. J Cell Biol (1971) 2.74
Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models. Am J Clin Nutr (2000) 2.71
Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosis. J Endocrinol Invest (1990) 2.70
Development and testing of nursing home quality indicators. Health Care Financ Rev (1995) 2.68
The development of the rat flexor digital tendon, a fine structure study. J Ultrastruct Res (1967) 2.61
Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents. Proc Natl Acad Sci U S A (1984) 2.58
Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest (1991) 2.58
Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med (1974) 2.55
Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell (1996) 2.55
Hyperlipidemia and atherosclerosis. Science (1976) 2.55
HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement. Am J Clin Pathol (2000) 2.53
Monoclonal antibodies to intermediate filament proteins of human cells: unique and cross-reacting antibodies. J Cell Biol (1982) 2.45
Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues. Am J Pathol (1984) 2.42
Human wound repair. I. Epidermal regeneration. J Cell Biol (1968) 2.39
A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. J Cell Biol (1985) 2.38
Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation (2000) 2.38
Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J Cell Biol (1981) 2.33
Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Natl Acad Sci U S A (1993) 2.31
Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell (1998) 2.29
Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol (1984) 2.29
Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis (1986) 2.27
Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb (1993) 2.27
Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst (1986) 2.27
Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am J Pathol (1986) 2.26
The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest (1995) 2.23
Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci U S A (1986) 2.20
Mediation of pinocytosis in cultured arterial smooth muscle and endothelial cells by platelet-derived growth factor. J Cell Biol (1978) 2.16
Induction of transforming growth factor-alpha in activated human alveolar macrophages. Cell (1988) 2.13
Human wound repair. II. Inflammatory cells, epithelial-mesenchymal interrelations, and fibrogenesis. J Cell Biol (1968) 2.11
Response to injury and atherogenesis. Am J Pathol (1977) 2.09
Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol. Hum Reprod (2010) 2.07
Human monocyte-derived growth factor(s) for mesenchymal cells: activation of secretion by endotoxin and concanavalin A. Cell (1981) 2.06
Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class. Proc Natl Acad Sci U S A (1988) 2.06
Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest (1980) 2.01
Structural analysis of repetitive DNA sequences in the bovine corticotropin-beta-lipotropin precursor gene region. Nucleic Acids Res (1982) 1.99
Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem (1997) 1.99
Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med (1992) 1.98
Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest (1994) 1.97
The neutrophilic leukocyte in wound repair a study with antineutrophil serum. J Clin Invest (1972) 1.96
Identification of a region in the human vasoactive intestinal polypeptide gene responsible for regulation by cyclic AMP. J Biol Chem (1987) 1.96
The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci U S A (1992) 1.94
Effects of antimicrotubular agents on the secretion of collagen. A biochemical and morphological study. J Cell Biol (1974) 1.93
An endothelial cell-derived growth factor. J Cell Biol (1980) 1.93
Economic status and survival of cancer patients. Cancer (1977) 1.93
Proteoglycans in primate arteries. I. Ultrastructural localization and distribution in the intima. J Cell Biol (1975) 1.93
George Lyman Duff Memorial Lecture. Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components. Arteriosclerosis (1982) 1.90
Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med (1995) 1.90
Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis (1984) 1.88